Vicky Makker, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, discusses 2 agents, lenvatinib and pembrolizumab, in patients with endometrial cancers.
Vicky Makker, MD
Articles by Vicky Makker, MD
Latest Updated Articles
Modest Response Rates in Endometrial CancersPublished: September 14th 2018 | Updated: